Candel Therapeutics Inc (CADL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | ||
| Net Income | -7,202 | -4,648 |
| Depreciation Amortization | 85 | 40 |
| Accounts payable and accrued liabilities | 827 | 9 |
| Other Working Capital | 1,007 | 135 |
| Other Operating Activity | -372 | 314 |
| Operating Cash Flow | $-5,655 | $-4,150 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | 19,296 | 19,302 |
| PPE Investments | -1,023 | -297 |
| Investing Cash Flow | $18,273 | $19,005 |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | 460 | 460 |
| Common Stock Issued | 1 | 1 |
| Financing Cash Flow | $461 | $461 |
| Beginning Cash Position | 5,445 | 5,445 |
| End Cash Position | 18,524 | 20,761 |
| Net Cash Flow | $13,079 | $15,316 |
| Free Cash Flow | ||
| Operating Cash Flow | -5,655 | -4,150 |
| Capital Expenditure | -1,023 | -297 |
| Free Cash Flow | -6,678 | -4,447 |